Approval · Notice of Compliance 16211 · 2014
OXPAM: Notice of Compliance 16211
Issued October 23, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16211
- Date
- October 23, 2014
- Company
- Biomed 2002 Inc
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Transfer of drug identification numbers
- Therapeutic class
- Anxiolytic - sedative